First Citizens Bank & Trust Co. Sells 523 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

First Citizens Bank & Trust Co. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 37.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 874 shares of the biotechnology company's stock after selling 523 shares during the quarter. First Citizens Bank & Trust Co.'s holdings in Axon Enterprise were worth $460,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise during the 4th quarter worth approximately $30,000. Elequin Capital LP purchased a new stake in Axon Enterprise during the 4th quarter valued at $46,000. Stonebridge Financial Group LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth approximately $53,000. CoreFirst Bank & Trust bought a new stake in shares of Axon Enterprise during the 4th quarter valued at $59,000. Finally, Global Financial Private Client LLC boosted its holdings in Axon Enterprise by 11,100.0% in the 1st quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock worth $59,000 after buying an additional 111 shares during the period. 79.08% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, President Joshua Isner sold 9,905 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, May 21st. The shares were sold at an average price of $738.03, for a total value of $7,310,187.15. Following the sale, the president now directly owns 298,809 shares in the company, valued at $220,530,006.27. This trade represents a 3.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,969 shares of company stock valued at $29,909,594 in the last quarter. Company insiders own 4.40% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Barclays increased their target price on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Bank of America lifted their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. Needham & Company LLC upped their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group boosted their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Finally, Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Trading Down 0.0%

Shares of AXON stock traded down $0.15 on Thursday, reaching $778.21. 71,448 shares of the stock were exchanged, compared to its average volume of 720,466. The stock has a market cap of $60.58 billion, a P/E ratio of 201.09, a price-to-earnings-growth ratio of 5.17 and a beta of 1.29. Axon Enterprise, Inc. has a 1-year low of $279.02 and a 1-year high of $806.64. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a 50 day moving average of $658.49 and a two-hundred day moving average of $619.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business's quarterly revenue was up 31.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.15 EPS. On average, research analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.